drugset / Trial / NCT00232167

Study Of Indiplon/Placebo With Sertraline In Insomnia Co-Existing With Depression

NCT00232167

Phase 3 Terminated 380 enrolled Neurocrine Biosciences
RandomizedParallel-groupDouble-blindTreatment

Summary

The goal of this study is to determine whether indiplon, when administered with sertraline, improves insomnia symptoms and depressive symptoms in subjects with both insomnia and depression.

Timeline

Start
2005-11
Primary completion
Completion
2006-04

Drugs

EvaluationDrugModalityDoseRoute
Subject Indiplon Small molecule
Background Sertraline Small molecule